Insider Transactions in Q2 2021 at Vertex Pharmaceuticals Inc (VRTX)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 02
2021
|
Sangeeta N. Bhatia Director |
SELL
Open market or private sale
|
Direct |
559
-3.34%
|
$116,831
$209.99 P/Share
|
|
Jun 01
2021
|
Margaret G Mcglynn Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
699
-38.88%
|
-
|
|
May 28
2021
|
Carmen Bozic EVP and CMO |
SELL
Payment of exercise price or tax liability
|
Direct |
311
-0.93%
|
$65,310
$210.04 P/Share
|
|
May 17
2021
|
David Altshuler EVP, Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
79
-0.08%
|
$17,064
$216.25 P/Share
|
|
May 17
2021
|
Stuart A Arbuckle EVP, COO |
SELL
Open market or private sale
|
Direct |
109
-0.09%
|
$23,544
$216.28 P/Share
|
|
May 17
2021
|
Joy Liu SVP, General Counsel |
SELL
Open market or private sale
|
Direct |
112
-0.67%
|
$24,192
$216.42 P/Share
|
|
May 17
2021
|
Amit Sachdev EVP Chief Patient & Ext Af Off |
SELL
Open market or private sale
|
Direct |
45
-0.04%
|
$9,720
$216.42 P/Share
|
|
May 17
2021
|
Bastiano Sanna EVP, Cell & Genetic Therapies |
SELL
Open market or private sale
|
Direct |
112
-0.16%
|
$24,192
$216.42 P/Share
|
|
May 03
2021
|
Bastiano Sanna EVP, Cell & Genetic Therapies |
SELL
Open market or private sale
|
Direct |
960
-1.38%
|
$209,280
$218.45 P/Share
|
|
May 01
2021
|
Sangeeta N. Bhatia Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,842
+24.26%
|
-
|
|
May 01
2021
|
Lloyd Carney Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,842
+25.43%
|
-
|
|
May 01
2021
|
Margaret G Mcglynn Director |
BUY
Grant, award, or other acquisition
|
Direct |
921
+33.87%
|
-
|
|
May 01
2021
|
Diana Mckenzie Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,842
+35.98%
|
-
|
|
Apr 30
2021
|
Bastiano Sanna EVP, Cell & Genetic Therapies |
SELL
Payment of exercise price or tax liability
|
Direct |
766
-2.14%
|
$166,222
$217.21 P/Share
|
|
Apr 30
2021
|
Charles F Wagner Jr EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
547
-1.55%
|
$118,699
$217.21 P/Share
|
|
Apr 27
2021
|
Amit Sachdev EVP Chief Patient & Ext Af Off |
SELL
Open market or private sale
|
Direct |
3,884
-3.01%
|
$838,944
$216.65 P/Share
|
|
Apr 27
2021
|
Amit Sachdev EVP Chief Patient & Ext Af Off |
BUY
Exercise of conversion of derivative security
|
Direct |
3,884
+8.11%
|
$334,024
$86.52 P/Share
|
|
Apr 05
2021
|
Bastiano Sanna EVP, Cell & Genetic Therapies |
SELL
Open market or private sale
|
Direct |
1,686
-2.27%
|
$360,804
$214.44 P/Share
|
|
Apr 01
2021
|
Bastiano Sanna EVP, Cell & Genetic Therapies |
SELL
Payment of exercise price or tax liability
|
Direct |
1,344
-3.46%
|
$287,616
$214.16 P/Share
|